Mail

Australia markets closed

ALL ORDS
8,013.80
+11.00(+0.14%)
ASX 200
7,767.50
+7.90(+0.10%)
AUD/USD
0.6669
+0.0018(+0.27%)
OIL
81.46
-0.28(-0.34%)
GOLD
2,336.90
+0.30(+0.01%)
Bitcoin AUD
90,328.45
-1,874.74(-2.03%)

Innovent Biologics, Inc. (1801.HK)

HKSE - HKSE Delayed price. Currency in HKD

Add to watchlist

36.800

-2.250

(-5.76%)

At close: 04:08PM HKT

Insider transactions

Insider transactions

Currency in HKD

Insider purchases - Last 6 months	Shares	Trans
Purchases	0	0
Sales	N/A	0
Net shares purchased (sold)	0	0
Total insider shares held	114.66M	N/A
% net shares purchased (sold)	N/A	N/A

Net institutional purchases - Prior quarter to latest quarter	Shares
Net shares purchased (sold)	N/A
% change in institutional shares held	N/A

Insider transactions reported - last two years

Insider	Transaction	Type	Value	Date	Shares
Yu (De-Chao Michael) Chief Executive Officer		Direct		31 Jan 2022	2,760,718
Chen (Kaixian) Independent Non-Executive Director		Direct		31 Jan 2022	4,702
Cooney (Charles Leland) Independent Non-Executive Director		Direct		31 Jan 2022	28
Hsu Joyce I-Yin Independent Non-Executive Director		Direct		31 Jan 2022	4,702
Ede (Hao Xi) Chief Financial Officer	Sale at price 11.20 per share.	Direct	47,285,455	22 July 2021	4,223,424
Yu (De-Chao Michael) Chief Executive Officer	Sale at price 13.11 per share.	Direct	25,392,133	25 Jan 2021	1,937,000
Yu (De-Chao Michael) Chief Executive Officer	Sale at price 12.87 per share.	Direct	13,682,510	22 Jan 2021	1,063,000
Ede (Hao Xi) Chief Financial Officer	Sale at price 11.73 per share.	Direct	17,590,050	21 Jan 2021	1,500,000
Yu (De-Chao Michael) Chief Executive Officer	Sale at price 6.45 per share.	Direct	58,054,500	27 July 2020	9,000,000
Ede (Hao Xi) Chief Financial Officer		Direct		20 Dec 2019	9,539,040
Yu (De-Chao Michael) Chief Executive Officer		Direct		20 Dec 2019	59,511,000